Effect of interventional therapy for ovarian function in patients with Adenomyosis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023477

Enrollment

Unknown

Registered

2019-05-30

Start date

2019-06-14

Completion date

Unknown

Last updated

2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopausal endometriosis

Interventions

A:Interventional therapy

B:Levonorgestrel intrauterine system

Eligibility

Sex/Gender

Female

Age

40 Years to 55 Years

Inclusion criteria

Inclusion criteria: Peri-menopausal patients with endometriosis, there are obvious symptoms: menstrual volume, dysmenorrhea obviously need to be treated, uterus increased for 3 months and reluctant to remove the uterus.

Exclusion criteria

Exclusion criteria: without interventional treatment.

Design outcomes

Primary

Measure	Time frame
Ovarian function test;Six sex hormones;Anti-Mullerian hormone;Dysmenorrhea;Menstrual volume;Uterine volume;Menopausal symptoms;Adenomyoma;	—

Countries

China

Contacts

Public ContactChen Ying

Chengdu Women and Children's Center Hospital

107276018@qq.com+86 18000515263

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026